IT
Illexcor Therapeutics, Inc.
SEC filingBiotechnology · Henrico, VA
Amount raised$13Msold at filing
Total offering$69M$56M still open
Investors in the raise6count reported to the SEC
FiledMay 8, 2026first sale Apr 15, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Timothy E LadinExecutive Officer
Andrew N FleischmanExecutive Officer, Director
Maneka E MirchandaneyDirector
Giovanni E MariggiDirector
Ted E LoveDirector
Executive officers, directors and promoters as listed on the Form D.